language-icon Old Web
English
Sign In
Acemap > Paper > 17 Use of Gefitinib (Iressa) in patients with EGFR positive NSCLC in the Pan Birmingham Cancer Network

17 Use of Gefitinib (Iressa) in patients with EGFR positive NSCLC in the Pan Birmingham Cancer Network

2012 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.